Vital Signs: Preventing Antibiotic‐Resistant Infections in Hospitals — United States, 2014. Issue 7 (July 2016)

• Record Type: Journal Article
• Authors: Weiner, Lindsey M.; Fridkin, Scott K.; Aponte‐Torres, Zuleika; Avery, Lacey; Coffin, Nicole; Dudeck, Margaret A.; Edwards, Jonathan R.; Jernigan, John A.; Konnor, Rebecca; Soe, Minn M.; Peterson, Kelly; Clifford McDonald, L.
• Is Part Of: American journal of transplantation. Volume 16:Issue 7(2016:Jul.)
• Page Start: 2224
• Page End: 2230
• Publication Date: 2016-07
• Subjects: Transplantation of organs, tissues, etc -- Periodicals; 617.95
• DOI: 10.1111/ajt.13893
• Languages: English
• ISSNs: 1600-6135

Abstract

Abstract : Background: Healthcare‐associated antibiotic‐resistant (AR) infections increase patient morbidity and mortality and might be impossible to successfully treat with any antibiotic. CDC assessed healthcare‐associated infections (HAI), including Clostridium difficile infections (CDI), and the role of six AR bacteria of highest concern nationwide in several types of healthcare facilities. Methods: During 2014, approximately 4000 short‐term acute care hospitals, 501 long‐term acute care hospitals, and 1135 inpatient rehabilitation facilities in all 50 states reported data on specific infections to the National Healthcare Safety Network. National standardized infection ratios and their percentage reduction from a baseline year for each HAI type, by facility type, were calculated. The proportions of AR pathogens and HAIs caused by any of six resistant bacteria highlighted by CDC in 2013 as urgent or serious threats were determined. Results: In 2014, the reductions in incidence in short‐term acute care hospitals and long‐term acute care hospitals were 50% and 9%, respectively, for central line‐associated bloodstream infection; 0% (short‐term acute care hospitals), 11% (long‐term acute care hospitals), and 14% (inpatient rehabilitation facilities) for catheter‐associated urinary tract infection; 17% (short‐term acute care hospitals) for surgical site infection, and 8% (short‐term acute care hospitals) for CDI. Combining HAIs other than CDI across all settings, 47.9% of Staphylococcus aureus isolates were methicillin resistant, 29.5% of enterococci were vancomycin resistant, 17.8% of Enterobacteriaceae were extended‐spectrum beta‐lactamase phenotype, 3.6% of Enterobacteriaceae were carbapenem resistant, 15.9% of Pseudomonas aeruginosa isolates were multidrug resistant, and 52.6% of Acinetobacter species were multidrug resistant. The likelihood of HAIs caused by any of the six resistant bacteria ranged from 12% in inpatient rehabilitation facilities to 29% in long‐term acute care hospitals. Conclusions: Although there has been considerable progress in preventing some HAIs, many remaining infections could be prevented with implementation of existing recommended practices. Depending upon the setting, more than one in four of HAIs excluding CDI are caused by AR bacteria. Implications for Public Health Practice: Physicians, nurses, and healthcare leaders need to consistently and comprehensively follow all recommendations to prevent catheter‐ and procedure‐related infections and reduce the impact of AR bacteria through antimicrobial stewardship and measures to prevent spread. Abstract : This report details the rates of antibiotic resistance in hospital‐acquired bacterial infections, important information for transplant patients given their increased risk for these infections.